Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23950)

Formulation Name
Dabigatran Etexilate Mesylate eq 110mg base capsule
Company
Boehringer Ingelheim
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Dabigatran etexilate DMRDZ4X Venous thromboembolism BD72 Phase 3
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carrageenan E00714 Not Available Emulsion stabilizing agent; Gelling agent; Microencapsulating agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Dimethicone 350 E00706 Not Available Antifoaming agent; Emollient; Water-repelling agent
FD&C blue no. 2 E00446 2723854 Colorant
Hydroxypropyl cellulose E00632 Not Available Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Hypromellose E00634 Not Available Coating agent
Potassium chloride E00074 4873 Tonicity agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Tartaric acid E00029 875 Acidulant; Complexing agent; Flavoring agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent